Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplanta...
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
About this item
Full title
Author / Creator
Pasvolsky, Oren , Wang, Zhongya , Milton, Denái R. , Tanner, Mark R. , Bashir, Qaiser , Srour, Samer , Saini, Neeraj , Lin, Paul , Ramdial, Jeremy , Nieto, Yago , Tang, Guilin , Kebriaei, Partow , Aljawai, Yosra , Khan, Hina N. , Lee, Hans C. , Ye, Christine , Patel, Krina K. , Thomas, Sheeba K. , Orlowski, Robert Z. , Shpall, Elizabeth J. , Champlin, Richard E. and Qazilbash, Muzaffar H.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Autologous stem cell transplantation (autoHCT) is considered standard of care for newly diagnosed multiple myeloma (MM). Although most patients eventually progress after autoHCT, a small proportion achieve a durable response. In this retrospective study we included 1576 patients, 244 (15%) of whom were long-term responders (LTR), defined as having...
Alternative Titles
Full title
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
Authors, Artists and Contributors
Author / Creator
Wang, Zhongya
Milton, Denái R.
Tanner, Mark R.
Bashir, Qaiser
Srour, Samer
Saini, Neeraj
Lin, Paul
Ramdial, Jeremy
Nieto, Yago
Tang, Guilin
Kebriaei, Partow
Aljawai, Yosra
Khan, Hina N.
Lee, Hans C.
Ye, Christine
Patel, Krina K.
Thomas, Sheeba K.
Orlowski, Robert Z.
Shpall, Elizabeth J.
Champlin, Richard E.
Qazilbash, Muzaffar H.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3d1f121b74294e0b9db9cfd7898d3a03
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3d1f121b74294e0b9db9cfd7898d3a03
Other Identifiers
ISSN
2044-5385
E-ISSN
2044-5385
DOI
10.1038/s41408-024-01062-2
